Evidence map›Paper›PMID 35306667›Full record

ArticleThe Journal of physiology2023

Exosomes and the cardiovascular system: role in cardiovascular health and disease.

Karla B Neves, Francisco J Rios, Javier Sevilla-Montero, Augusto C Montezano, Rhian M Touyz

Open access · hybridAbstract read
In one paragraph

Article in The Journal of physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Extracellular Vesicle Preparation and Analysis: A State-of-the-Art Review.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Karla B NevesInstitute of Cardiovascular and Medical Sciences, University of Glasgow, UK.ORCID 0000-0001-5158-9263
Francisco J RiosInstitute of Cardiovascular and Medical Sciences, University of Glasgow, UK.
Javier Sevilla-MonteroBiomedical Research Institute La Princesa Hospital (IIS-IP), Department of Medicine, School of Medicine, Universidad Autónoma of Madrid (UAM), Madrid, Spain.
Augusto C MontezanoInstitute of Cardiovascular and Medical Sciences, University of Glasgow, UK.
Rhian M TouyzInstitute of Cardiovascular and Medical Sciences, University of Glasgow, UK.ORCID 0000-0003-0670-0887
University of Glasgow · GBMcGill University Health Centre · CAUniversidad Autónoma de Madrid · ES

Funding

British Heart Foundation CH/12/4/29762
6 · The paper itself

Abstract

Exosomes, which are membrane-bound extracellular vesicles (EVs), are generated in the endosomal compartment of almost all eukaryotic cells. They are formed upon the fusion of multivesicular bodies and the plasma membrane and carry proteins, nucleic acids, lipids and other cellular constituents from their parent cells. Multiple factors influence their production including cell stress and injury, humoral factors, circulating toxins, and oxidative stress. They play an important role in intercellular communication, through their ability to transfer their cargo (proteins, lipids, RNAs) from one cell to another. Exosomes have been implicated in the pathophysiology of various diseases including cardiovascular disease (CVD), cancer, kidney disease, and inflammatory conditions. In addition, circulating exosomes may act as biomarkers for diagnostic and prognostic strategies for several pathological processes. In particular exosome-containing miRNAs have been suggested as biomarkers for the diagnosis and prognosis of myocardial injury, stroke and endothelial dysfunction. They may also have therapeutic potential, acting as vectors to deliver therapies in a targeted manner, such as the delivery of protective miRNAs. Transfection techniques are in development to load exosomes with desired cargo, such as proteins or miRNAs, to achieve up-regulation in the host cell or tissue. These advances in the field have the potential to assist in the detection and monitoring progress of a disease in patients during its early clinical stages, as well as targeted drug delivery.

Indexed as

Cardiovascular SystemExosomesExtracellular VesiclesMicroRNAsBiomarkersHumansLipidsProteinsBiomarkersLipidsMicroRNAsProteinsbiomarkerscardiovascular systemexosomestherapeutic target

Identifiers

PMID35306667
PMCPMC10953460
OpenAlexW4220663569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.